✦ LIBER ✦

Treatment of Chronic Phase Chronic Myeloid Leukemia with Imatinib

✍ Scribed by Ganesan, Prasanth; Rajendranath, Rejiv; Kandakumar, Vignesh; Sagar, Tenali Gnana

Book ID: 125378339
Publisher: Springer-Verlag
Year: 2014
Tongue: English
Weight: 207 KB
Volume: 82
Category: Article
ISSN: 0019-5456
DOI: 10.1007/s12098-014-1492-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dasatinib: From Treatment of Imatinib-Re

Dasatinib: From Treatment of Imatinib-Resistant or -Intolerant Patients With Chronic Myeloid Leukemia to Treatment of Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

✍ Brian L. Abbott 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Molecular responses of late chronic phas

Molecular responses of late chronic phase chronic myeloid leukemia patients after achieving complete cytogenetic responses with imatinib treatment: a 6-year follow-up

✍ YaZhen Qin; Bin Jiang; Qian Jiang; Hao Jiang; JinLan Li; Yan Zhang; HongHu Zhu; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 117 KB

Velocity of early BCR-ABL transcript eli

Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib

✍ Hanfstein, B; Shlyakhto, V; Lauseker, M; Hehlmann, R; Saussele, S; Dietz, C; Erb 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 599 KB

Imatinib as the first-line treatment of

Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials?

✍ Daniela Zackova; Hana Klamova; Ladislav Dusek; Jan Muzik; Katerina Machova Polak 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views

PCN57 Cost Effectiveness of Nilotinib Ve

PCN57 Cost Effectiveness of Nilotinib Versus Imatinib as First Line Treatment for Newly Diagnosed Hong Kong (HK) Patients With Chronic Phase, Philadelphia Chromosome-Positive (PH+) Chronic Myeloid Leukemia in the Chronic Phase (CML-CP) in Hong Kong

✍ Tse, V.; Liu, H.; Botteman, M.; Mcghee, S.; Lee, V.W.; Lee, K.K. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PCN92 Cost-Effectiveness of Nilotinib Ve

PCN92 Cost-Effectiveness of Nilotinib Versus Imatinib as First-Line Treatment for Newly Diagnosed Patients With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in the Chronic Phase (CML-CP) in Russian Federation

✍ R. Yagudina; A. Kulikov; I. Komarov 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB